Neuromodulation Devices Market, By Device Type (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices), By Application (Pain Management, Neu

Neuromodulation Devices Market, By Device Type (Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, Vagus Nerve Stimulation Devices, Gastric Electric Stimulation Devices), By Application (Pain Management, Neurological and Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism & GIT Management, Incontinence Management, Others), By End User (Hospitals, Specialty Clinics, Ambulatory Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Electrical stimulation uses electrotherapy for treating spinal injuries and muscle weakness associated with neurological disorders. It has property to activate electrical impulse and transmit signal to electrodes of device, which causes depolarization and in turn reduces pain and improves muscle strength. Different types of electrical stimulation devices are designed to treat various diseases such as pain management, obesity, and others.

Restraints of the Global Neuromodulation Devices Market

Side effects and risks associated with the use of neuromodulation devices are expected to hinder growth of the global neuromodulation devices market.

Key features of the study:

  • This report provides in-depth analysis of the global neuromodulation devices market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global neuromodulation devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Axonics Modulation Technologies, Inc., ShiraTronics, Inc., Bioness, Inc., LivaNova, Neuronetics, Inc., Medtronic plc, St. Jude Medical, Boston Scientific Corporation, Cyberonics, Nevro, Integer Holdings Corporation, and Uroplasty
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global neuromodulation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
  • Global Neuromodulation Devices Market, By Device Type:
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
  • Global Neuromodulation Devices Market, By Application:
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism & GIT Management
  • Incontinence Management
  • Others
  • Global Neuromodulation Devices Market, By End User:
  • Hospitals
  • Specialty Clinics
  • Ambulatory Centers
  • Others
  • Global Neuromodulation Devices Market, By Geography:
  • North America
  • By Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
  • By Application:
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism & GIT Management
  • Incontinence Management
  • Others
  • By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Centers
  • Others
  • By Country:
  • U.S.
  • Canada
  • Europe
  • By Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
  • By Application:
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism & GIT Management
  • Incontinence Management
  • Others
  • By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Centers
  • Others
  • By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
  • By Application:
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism & GIT Management
  • Incontinence Management
  • Others
  • By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Centers
  • Others
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • By Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
  • By Application:
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism & GIT Management
  • Incontinence Management
  • Others
  • By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Centers
  • Others
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East:
  • By Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
  • By Application:
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism & GIT Management
  • Incontinence Management
  • Others
  • By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Centers
  • Others
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Device Type
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Gastric Electric Stimulation Devices
  • By Application:
  • Pain Management
  • Neurological and Movement Disorder Management
  • Musculoskeletal Disorder Management
  • Metabolism & GIT Management
  • Incontinence Management
  • Others
  • By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Centers
  • Others
  • By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Axonics Modulation Technologies, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • ShiraTronics, Inc.
  • Bioness, Inc.
  • LivaNova
  • Neuronetics, Inc.
  • Medtronic plc
  • St. Jude Medical
  • Boston Scientific Corporation
  • Cyberonics
  • Nevro
  • Integer Holdings Corporation
  • Uroplasty
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Device Type
Market Snippet, By Application
Market Snippet, By End User
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Technological Advancement
Regulatory Scenario
4. Global Neuromodulation Devices Market, By Device Type, 2017 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2019–2027
Segment Trends
Spinal Cord Stimulation Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Deep Brain Stimulation Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Sacral Nerve Stimulation Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Vagus Nerve Stimulation Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
Gastric Electric Stimulation Devices
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Segment Trends
5. Global Neuromodulation Devices Market, By Application, 2017 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2019–2027
Segment Trends
Pain Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Neurological and Movement Disorder Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Musculoskeletal Disorder Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Metabolism & GIT Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Incontinence Management
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
6. Global Neuromodulation Devices Market, By End User, 2017 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2019–2027
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Ambulatory Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
7. Global Neuromodulation Devices Market, By Regions, 2017 – 2027 (US$ Mn)
Introduction
Market Share Analysis, 2019 and 2027 (%)
Y-o-Y Growth Analysis, 2019–2027
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Company Profiles
Axonics Modulation Technologies, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
ShiraTronics, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Bioness, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
LivaNova
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Neuronetics, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Medtronic plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
St. Jude Medical
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Boston Scientific Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Cyberonics
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Nevro
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Integer Holdings Corporation
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Uroplasty
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 37 market data tables and 25 figures on “Neuromodulation Devices Market – Global forecast to 2027.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook